Peter Diamandis

Rank 8 of 47

Score 139

Doctors created a custom-designed gene-editing CRSPR based treatment that was delivered directly into his body, especially tailored for his UNIQUE genetic sequence: a shift towards precision medicine for rare diseases.

6/3/2025, 8:01:42 PM

In reply to:

Peter H. Diamandis, MD

@PeterDiamandis

10d

KJ Muldoon (7 months old) was diagnosed with CPS1 deficiency (a disorder where the liver can't break down ammonia, leading to death), with the only known cure being a liver transplant, an extremely challenging and unfeasible solution.

Peter H. Diamandis, MD

@PeterDiamandis

10d

Personalized gene Editing will save YOU next.

We have a WORKING again a proof-of-concept for personalized gene-editing. An infant received the first in vivo CRISPR gene-edited therapy for a CPS1 deficiency.

This is HUGE, here's the breakthrough of this case:

The statement discusses a significant advancement in precision medicine, specifically the use of CRISPR gene-editing technology to treat a rare genetic disorder. It highlights the potential of personalized medicine to address previously unmanageable conditions, contributing to public discourse on medical innovation and healthcare solutions.

Principle 1:
I will strive to do no harm with my words and actions.
The statement promotes a positive development in medicine, potentially reducing harm by offering new treatment options for rare diseases. [+2]
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.
It fosters understanding and awareness of advancements in gene-editing technology, encouraging empathy for those affected by rare diseases. [+2]
Principle 6:
I will use my influence for the betterment of society.
The statement uses its platform to highlight a breakthrough in medical science, contributing to societal betterment by informing the public about new healthcare possibilities. [+2]